Literature DB >> 191218

Type III hyperlipoproteinemia: a comparative study of current diagnostic techniques.

J J Albers, G R Warnick, W R Hazzard.   

Abstract

Research into the prevalence, genetic transmission and pathophysiology of Type III hyperlipoproteinemia has suffered from the lack of a practical specific diagnostic procedure. In this study, very low density lipoprotein (VLDL) compositional criteria were established in a population lacking the beta-migrating VLDL characteristic of this disorder. Diagnosis by these criteria was compared to diagnosis using current criteria for the Type III lipoprotein pattern. In addition two techniques for detecting Type III without preliminary VLDL isolation by ultracentrifugation were evaluated. Plasma triglyceride (TG) concentration dependent cutlines for the compositional criteria reduced false positives at low TG levels and false negatives at high TG levels. Furthermore, an agarose electrophoresis heparin-manganese precipitation technique was effective for screening for a possible Type III pattern in plasma whereas the combination agarose-polyacrylamide gel electrophoresis system was not effective.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 191218     DOI: 10.1016/0009-8981(77)90190-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  A case of type III hyperlipoproteinaemia studied by acrylamide gel gradient electrophoresis.

Authors:  M Y Chew; J M Gutman; J Green
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

2.  Plasma, apolipoprotein, A-I and A-II levels in hyperlipidemia.

Authors:  G Schonfeld; A Bailey; R Steelman
Journal:  Lipids       Date:  1978-12       Impact factor: 1.880

Review 3.  Hyperlipoproteinemia type 3: the forgotten phenotype.

Authors:  Paul N Hopkins; Eliot A Brinton; M Nazeem Nanjee
Journal:  Curr Atheroscler Rep       Date:  2014-09       Impact factor: 5.113

4.  Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

Authors:  Paul N Hopkins; M Nazeem Nanjee; Lily L Wu; Michael G McGinty; Eliot A Brinton; Steven C Hunt; Jeffrey L Anderson
Journal:  Atherosclerosis       Date:  2009-05-22       Impact factor: 5.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.